Table 2.
Distribution of Patient Characteristics and Adjusted Mean for Key Patient-Reported Outcomes
| N (%) | Symptomsa | Optimismb | Anxietyb | PCSb | MCSb | |
|---|---|---|---|---|---|---|
| All | 215 (100) | 43.37 | 71.64 | 63.41 | 43.66 | 50.08 |
| Individual-level inputs | ||||||
| Stage | ns | ns | ns | ns | ns | |
| I | 58 (27.0) | 43.20 | 70.95 | 62.84 | 44.34 | 49.77 |
| II | 22 (10.2) | 47.73 | 71.59 | 67.17 | 44.20 | 50.42 |
| III | 116 (54.0) | 43.71 | 71.94 | 63.98 | 43.10 | 50.08 |
| IV | 10 (4.7) | 35.00 | 66.67 | 50.00 | 42.34 | 47.27 |
| Unstaged | 9 (4.2) | 38.89 | 77.78 | 65.43 | 46.67 | 54.36 |
| Age at diagnosis | * | ns | * | ns | ns | |
| Q1 (≤51) | 36 (16.7) | 42.09 | 74.09 | 66.67 | 46.04 | 50.43 |
| Q2 (51–≤58) | 67 (31.2) | 49.35 | 70.94 | 54.30 | 42.66 | 48.14 |
| Q3 (58–≤66) | 50 (23.3) | 43.57 | 74.40 | 66.67 | 43.77 | 52.93 |
| Q4 (66>) | 62 (28.8) | 37.50 | 67.84 | 67.86 | 42.93 | 49.14 |
| Comorbiditya | ns | ** | ns | *** | * | |
| 0,1 | 130 (60.5) | 42.66 | 74.59 | 66.07 | 45.65 | 50.87 |
| 2 | 30 (14.0) | 43.67 | 72.67 | 63.70 | 42.48 | 52.86 |
| 3+ | 55 (25.6) | 44.91 | 64.09 | 56.97 | 39.61 | 46.71 |
| BMIa | ns | ns | ns | ** | ns | |
| <25 | 35 (16.4) | 41.30 | 71.79 | 69.84 | 47.13 | 52.05 |
| 25–<30 | 53 (24.8) | 42.83 | 71.54 | 64.36 | 45.58 | 51.16 |
| ≥30 | 126 (58.9) | 44.29 | 71.61 | 61.02 | 41.86 | 49.03 |
| Physical activity, MET-min/weeka | ns | ns | *** | * | ns | |
| Q1 (0) | 74 (34.4) | 46.76 | 68.10 | 50.60 | 41.31 | 47.75 |
| Q2 (0–≤265) | 34 (15.8) | 45.59 | 73.90 | 64.71 | 43.71 | 50.08 |
| Q3 (265–≤720) | 62 (28.8) | 40.97 | 71.05 | 69.18 | 43.71 | 52.13 |
| Q4 (>720) | 45 (20.9) | 39.46 | 76.56 | 75.56 | 47.43 | 51.10 |
| Social/societal-level inputs | ||||||
| Social supporta | ns | *** | * | ** | ** | |
| Low (≤3) | 10 (4.7) | 46.00 | 50.42 | 48.89 | 33.25 | 41.46 |
| Moderate (3–<4) | 81 (38.4) | 43.33 | 69.05 | 59.81 | 43.07 | 49.01 |
| High (>4) | 120 (56.9) | 43.05 | 74.93 | 66.30 | 44.77 | 51.36 |
| SES: Family income | ns | *** | *** | * | ns | |
| <10 K | 40 (18.9) | 45.50 | 63.17 | 46.11 | 40.48 | 47.98 |
| 10k–<25k | 55 (25.9) | 39.45 | 68.02 | 64.65 | 41.83 | 48.34 |
| 25k–<50k | 56 (26.4) | 46.71 | 75.76 | 66.47 | 43.97 | 49.95 |
| 50k–<75k | 32 (15.1) | 48.13 | 75.26 | 68.06 | 47.03 | 52.98 |
| ≥75k | 29 (13.7) | 36.21 | 78.16 | 71.65 | 47.21 | 53.24 |
| SES: education | ns | *** | *** | ns | ns | |
| <HS | 35 (16.3) | 34.86 | 63.26 | 51.75 | 41.69 | 46.73 |
| HS | 58 (27.0) | 45.96 | 66.65 | 57.47 | 42.71 | 49.08 |
| Some college | 58 (27.0) | 45.34 | 78.45 | 67.24 | 43.19 | 51.75 |
| ≥4 years college | 64 (29.8) | 43.91 | 74.56 | 71.70 | 46.03 | 51.31 |
| Perceived discriminationb | * | ns | ns | ns | ns | |
| 0 (None) | 115 (53.5) | 39.83 | 71.22 | 65.12 | 44.38 | 50.52 |
| >0 (Any) | 100 (46.5) | 47.46 | 72.12 | 61.44 | 42.84 | 49.58 |
| Any chemotherapy | ns | ns | ns | ns | ns | |
| No | 17 (9.8) | 40.59 | 76.23 | 73.86 | 42.10 | 51.49 |
| Yes | 156 (90.1) | 44.33 | 70.65 | 64.96 | 44.08 | 49.98 |
a
Initial interview scores.
b
Follow-up interview scores.
ns = Comparisons not statistically significant.
*
p-value <0.05.
**
p-value <0.01.
***
p-value <0.001.